Titan Pharmaceuticals's total assets for Q2 2025 were $3.05M, an increase of 41.51% from the previous quarter. TTNP total liabilities were $263.00K for the fiscal quarter, a -5.73% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.